NLI Holdings, Inc. (NL) stock
NLNYSEIndustrial Inorganic ChemicalsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/307% below fair value
$7.11+0.04 (+0.57%)
Close on Nov 16, 2026Market cap $347.67MP/E –Yield 8.02%
NLI EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
NLI's EPS for the twelve months ending Jun 30, 2026 was -$0.52, down 147.3% year over year. For fiscal 2025 it was -$0.77, down 155.8% from the year before. The highest annual figure on record is $2.38 in fiscal 2017.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.77 | -155.8% |
| FY2024 | Dec 31, 2024 | $1.38 | – |
| FY2023 | Dec 31, 2023 | -$0.05 | -107.2% |
| FY2022 | Dec 31, 2022 | $0.69 | -34.3% |
| FY2021 | Dec 31, 2021 | $1.05 | +250.0% |
| FY2020 | Dec 31, 2020 | $0.30 | -43.4% |
| FY2019 | Dec 31, 2019 | $0.53 | – |
| FY2018 | Dec 31, 2018 | -$0.84 | -135.3% |
| FY2017 | Dec 31, 2017 | $2.38 | +667.7% |
| FY2016 | Dec 31, 2016 | $0.31 | – |
| FY2015 | Dec 31, 2015 | -$0.49 | -183.1% |
| FY2014 | Dec 31, 2014 | $0.59 | – |
| FY2013 | Dec 31, 2013 | -$1.14 | -174.5% |
| FY2012 | Dec 31, 2012 | $1.53 | -8.9% |
| FY2011 | Dec 31, 2011 | $1.68 | +20.0% |
| FY2010 | Dec 31, 2010 | $1.40 | – |
| FY2009 | Dec 31, 2009 | -$0.24 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.18 | +1700.0% |
| Q1 FY2026 | Mar 31, 2026 | $0.09 | +800.0% |
| Q4 FY2025 | Dec 31, 2025 | -$0.63 | -285.3% |
| Q3 FY2025 | Sep 30, 2025 | -$0.16 | -121.6% |
| Q2 FY2025 | Jun 30, 2025 | $0.01 | -93.8% |
| Q1 FY2025 | Mar 31, 2025 | $0.01 | -92.9% |
| Q4 FY2024 | Dec 31, 2024 | $0.34 | +112.5% |
| Q3 FY2024 | Sep 30, 2024 | $0.74 | – |
| Q2 FY2024 | Jun 30, 2024 | $0.16 | – |
| Q1 FY2024 | Mar 31, 2024 | $0.14 | – |
| Q4 FY2023 | Dec 31, 2023 | $0.16 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.00 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | -$0.06 | -108.1% |
| Q1 FY2023 | Mar 31, 2023 | -$0.14 | -145.2% |
| Q3 FY2022 | Sep 30, 2022 | -$0.18 | -185.7% |
| Q2 FY2022 | Jun 30, 2022 | $0.62 | +138.5% |
| Q1 FY2022 | Mar 31, 2022 | $0.74 | +174.1% |
| Q4 FY2021 | Dec 31, 2021 | $0.31 | +244.4% |
| Q3 FY2021 | Sep 30, 2021 | $0.21 | +162.5% |
| Q2 FY2021 | Jun 30, 2021 | $0.26 | +188.9% |
| Q1 FY2021 | Mar 31, 2021 | $0.27 | +575.0% |
| Q4 FY2020 | Dec 31, 2020 | $0.09 | -30.8% |
| Q3 FY2020 | Sep 30, 2020 | $0.08 | – |
| Q2 FY2020 | Jun 30, 2020 | $0.09 | -25.0% |
| Q1 FY2020 | Mar 31, 2020 | $0.04 | -87.1% |
| Q4 FY2019 | Dec 31, 2019 | $0.13 | +116.7% |
| Q3 FY2019 | Sep 30, 2019 | -$0.03 | – |
| Q2 FY2019 | Jun 30, 2019 | $0.12 | – |
| Q1 FY2019 | Mar 31, 2019 | $0.31 | +6.9% |
| Q4 FY2018 | Dec 31, 2018 | $0.06 | -94.0% |
| Q3 FY2018 | Sep 30, 2018 | -$0.32 | -188.9% |
| Q2 FY2018 | Jun 30, 2018 | -$0.87 | -202.4% |
| Q1 FY2018 | Mar 31, 2018 | $0.29 | +70.6% |
| Q4 FY2017 | Dec 31, 2017 | $1.00 | +400.0% |
| Q3 FY2017 | Sep 30, 2017 | $0.36 | +140.0% |
| Q2 FY2017 | Jun 30, 2017 | $0.85 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.17 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.20 | – |
| Q3 FY2016 | Sep 30, 2016 | $0.15 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?